2015
DOI: 10.1007/s40520-015-0380-x
|View full text |Cite
|
Sign up to set email alerts
|

Olfaction deterioration in cognitive disorders in the elderly

Abstract: Alzheimer's and Parkinson's diseases are both neurodegenerative disorders typically found in the elderly. As both diseases are characterized by the early presence of dysosmia, simple validated smell tests could very well help clinicians in the early diagnosis of these neuropathological conditions. Elderly patients complaining of smell loss and found to be dysosmic, by means of validated olfactory tests, should be neurologically evaluated as early as possible to detect slight motor abnormalities in an at-risk p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
35
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 51 publications
(38 citation statements)
references
References 84 publications
1
35
0
2
Order By: Relevance
“…Overall, our findings suggest the recognition of a potential time point from our work with the olfactory bulb and the idea that loss of olfaction is an early-enough marker in neurodegeneration to recognize that the initiation of strategies which will overcome a continuing loss of cognitive abilities will need to be considered and implemented [40][41][42].…”
Section: Discussionmentioning
confidence: 99%
“…Overall, our findings suggest the recognition of a potential time point from our work with the olfactory bulb and the idea that loss of olfaction is an early-enough marker in neurodegeneration to recognize that the initiation of strategies which will overcome a continuing loss of cognitive abilities will need to be considered and implemented [40][41][42].…”
Section: Discussionmentioning
confidence: 99%
“…Where a patient complains of reduced or dysfunctional taste, often they are in fact suffering from olfactory impairment and describing consequent impact on flavour perception (95) (178) . Where a patient has previously been treated with corticosteroids with improvement in smell, it is likely that they are suffering from sinonasal disease.…”
Section: Idiopathic Olfactory Dysfunctionmentioning
confidence: 99%
“…Exposure to air pollution, particularly fine particulate matter (PM2.5), also leads to reduced sense of smell and anosmia (Ajmani et al, 2016a;Ajmani et al, 2016b) and can damage nasal tissue (Calderon-Garciduenas et al, 2003). Interestingly, anosmia and a decline of sense of smell precede the onset of neurodegenerative disorders (Doty, 1989;Wilson et al, 2009;Rahayel et al, 2012;Growdon et al, 2015;Ottaviano et al, 2016;Roberts et al, 2016;Murphy, 2019) and is also associated with depressive disorders (Croy et al, 2014;Kohli et al, 2016). Similar damage and sensory deficits have been implicated in COVID-19 pathology (Cooper et al, 2020).…”
Section: Introductionmentioning
confidence: 99%